American Society of Clinical Oncology

SHERPA: White

People

  1. Pfister
    Pfister
  2. Lee
    Lee
  3. Sherman
    Sherman
  4. Dunn
    Dunn
  5. Ho
    Ho
  6. McBride
    McBride
  7. Michel
    Michel
  8. Riaz
    Riaz
  9. Zhang
    Zhang
  10. Aghalar
    Aghalar

Groups

  1. Biostatistics Service (5)
  2. Department of Medicine (5)
  3. Epidemiology and Biostatistics (5)
  4. Head and Neck Service (5)
  5. Solid Tumor Oncology Division (5)
  6. Thoracic Oncology (5)
  7. Radiation Oncology, Department of (4)
  8. Survivorship Research (4)
  9. Neuroradiology Service (3)
  10. Radiology, Department of (3)
Search Within
  1. "David Pfister"
  2. "Thoracic Oncology"
  3. "Biostatistics Service"
Formats
  1. Meeting Abstract (3)
  2. Journal Article (2)
Groups
  1. Biostatistics Service (5)
  2. Department of Medicine (5)
  3. Epidemiology and Biostatistics (5)
  4. Head and Neck Service (5)
  5. Solid Tumor Oncology Division (5)
  6. Thoracic Oncology (5)

More Groups

People
  1. David Pfister (5)
  2. Eric Sherman (4)
  3. Nancy Lee (4)
  4. Alan Ho (3)
  5. Chiaojung Jillian Tsai (3)
  6. Lara Dunn (3)

More People

Years
  1. 2024 (1)
  2. 2022 (1)
  3. 2021 (1)
  4. 2018 (1)
  5. 2013 (1)
Publications
  1. Journal of Clinical Oncology (5)

Results (5)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Hypoxia-directed treatment of human papillomavirus-related oropharyngeal carcinoma
    Journal Article

    Lee, N. Y.; Sherman, E. J.; Schòˆder, H.; Wray, R.; Boyle, J. O.; Singh, B.; Grkovski, M.; Paudyal, R.; Cunningham, L.; Zhang, Z.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Assessing effectiveness of first-line carboplatin, pemetrexed, and pembrolizumab in patients with recurrent/metastatic lung adenocarcinoma
    Meeting Abstract

    Ip, A.; Gutierrez, M.; Warren, M. E.; Pfister, D. G.; Brady, O.; Shen, R. L.; Riely, G. J.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Randomized phase II trial of nivolumab with stereotactic body radiotherapy versus nivolumab alone in metastatic head and neck squamous cell carcinoma
    Journal Article

    McBride, S.; Sherman, E.; Tsai, C. J.; Baxi, S.; Aghalar, J.; Eng, J.; Zhi, W. I.; McFarland, D.; Michel, L. S.; Young, R.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • A phase II randomized trial of nivolumab with stereotactic body radiotherapy (SBRT) versus nivolumab alone in metastatic (M1) head and neck squamous cell carcinoma (HNSCC)
    Meeting Abstract

    McBride, S. M.; Sherman, E. J.; Tsai, C. J.; Baxi, S. S.; Aghalar, J.; Eng, J.; Zhi, W. I.; McFarland, D. C.; Michel, L. S.; Spielsinger, D.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Phase I study of weekly albumin-bound paclitaxel (ab-P) plus weekly cetuximab (Cet) plus intensity-modulated radiation therapy (IMRT) in patients with stage III/IVb head and neck squamous cell carcinoma (HNSCC)
    Meeting Abstract

    Fury, M. G.; Sherman, E. J.; Rao, S. S.; Wolden, S. L.; Smith-Marrone, S.; Ng, K. K.; Mueller, B.; Gelblum, D. Y.; Dutta, P. R.; Lee, J.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save